Grants per year
Grants
- 23 Finished
Search results
-
Finished
Treating cognitive impairments in cancer patients via systematic light exposure
Wu, L. M. (PD/PI), Mehta, J. (Other), Mroczek, D. K. (Other), Penedo, F. J. (Other) & Zee, P. C. (Other)
11/20/15 → 10/16/19
Project: Research project
-
Prot #0113-CL-1004: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell
Mehta, J. (PD/PI)
CTI Clinical Trial and Consulting Services, Astellas Pharma Global Development, Inc.
8/29/14 → 8/29/17
Project: Research project
-
Prot #TK008: Randomized phase III trial of haploidentical HCT with or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemia
Mehta, J. (PD/PI)
8/22/12 → 6/20/18
Project: Research project
-
Prot # V212-001: A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs)
Mehta, J. (PD/PI)
Clinical Financial Services, LLC, Merck Sharp & Dohme Corporation
7/1/11 → 6/20/18
Project: Research project
-
A Genome Wide Admixture Scan of Multiple Myeloma in African-Americans
Singhal, S. (PD/PI) & Mehta, J. (Co-Investigator)
University of Southern California, National Cancer Institute
8/1/10 → 5/31/15
Project: Research project
-
Prot # X05317: A Phase 2 Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
Jain, M. (PD/PI) & Mehta, J. (Co-Investigator)
Millennium Pharmaceuticals, Inc.
10/23/09 → 10/23/18
Project: Research project
-
Prot# 265: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion in Combination with Corticosteroids for the Treatment of Newly Diagn
Mehta, J. (PD/PI)
Quintiles, Inc., Osiris Therapeutics, Inc.
6/5/08 → 6/5/11
Project: Research project
-
Research on Adverse Drug Events and Reports: Novel Multiple Myeloma Drugs
West, D. P. (PD/PI), Belknap, S. M. (Co-PD/PI), Kuzel, T. M. (Co-PD/PI), Kwaan, H. C. (Co-PD/PI), McKoy, J. M. (Co-PD/PI), Mehta, J. (Co-PD/PI), Singhal, S. (Co-PD/PI) & Tallman, M. S. (Co-PD/PI)
9/6/07 → 8/31/11
Project: Research project
-
High-Throughput Stem Cell Procurement and Purification for Cell-Based Therapies
Mehta, J. (PD/PI) & Singhal, S. (Co-PD/PI)
University of Illinois at Urbana-Champaign, Illinois Department of Public Health
5/21/07 → 5/20/09
Project: Research project
-
Prot# 280: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Steroid-Refractory Acute GVHD
Mehta, J. (PD/PI)
Quintiles, Inc., Osiris Therapeutics, Inc.
3/15/07 → 1/1/12
Project: Research project
-
Prot# CG53135-CLN-12: A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Mehta, J. (PD/PI)
PPD Development, CuraGen Corporation
8/25/06 → 3/1/12
Project: Research project
-
Prot# NU 06H2: A Multicenter Phase II Study Incorporating DOXIL® and Rituximab into the Magrath Regimen for HIV-Negative and HIV-Positive Patients with Newly Diagnosed Burkitt's and Burkitt-like Lymphoma
Frankfurt, O. (Co-PD/PI), Gordon, L. I. (Co-PD/PI), Kuzel, T. M. (Co-PD/PI), Mehta, J. (Co-PD/PI), Singhal, S. (Co-PD/PI), Tallman, M. S. (Co-PD/PI) & Winter, J. N. (Co-PD/PI)
Ortho Biotech Clinical Affairs, LLC
8/3/06 → 4/1/12
Project: Research project
-
Prot# X05211: A Phase II Trial of Combination Bortezomib and Rituximab as Front-Line Therapy for Low-Grade Non-Hodgkin's Lymphoma (NU Prot# NU 06H1)
Gordon, L. I. (PD/PI), Frankfurt, O. (Co-PD/PI), Kuzel, T. M. (Co-PD/PI), Mehta, J. (Co-PD/PI), Singhal, S. (Co-PD/PI), Tallman, M. S. (Co-PD/PI) & Winter, J. N. (Co-PD/PI)
Millennium Pharmaceuticals, Inc.
6/29/06 → 1/31/20
Project: Research project
-
Prot# AMD3100-3101: Mltctr, Rndmzd, Dbl-Bld, Plcbo-Cntrld, Comparative Trial of AMD3100 (240µg/kg) + G-CSF (10µg/kg) vs G-CSF (10µg/kg) + Placebo to Mobilze & Collect =>5x10(6) CD34+ Cells/kg in Non-Hodgkin's Lymphoma Ptnts for Autologous Transplantation
Mehta, J. (PD/PI)
11/15/05 → 6/1/12
Project: Research project
-
Prot# AMD3100-3102: Mltctr, Rndmzd, Dbl-Bld, Plcbo-Cntrld, Comparative Trial of AMD3100 (240 µg/kg) + G-CSF (10 µg/kg) vs G-CSF (10µg/kg) + Placebo to Mobilize & Collect =>6x10(6) CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation
Mehta, J. (PD/PI)
11/15/05 → 12/1/11
Project: Research project
-
Prot# B9E-US-X446: A Phase I/II Trial of Combination Bortezomib (VELCADE®) and Gemcitabine Therapy for Patients with Relapsed or Refractory Aggressive B- and T -Cell Non-Hodgkin's Lymphoma (NU Prot# NU 04H4)
Gordon, L. I. (PD/PI), Gordon, L. I. (Co-PD/PI), Kuzel, T. M. (Co-PD/PI), Mehta, J. (Co-PD/PI), Platanias, L. C. (Co-PD/PI), Singhal, S. (Co-PD/PI), Tallman, M. S. (Co-PD/PI), Williams, S. F. (Co-PD/PI) & Winter, J. N. (Co-PD/PI)
9/12/05 → 10/31/17
Project: Research project
-
Prot# VEL-03-082: A Phase I/II Trial of Combination Bortezomib (VELCADE®) and Gemcitabine Therapy for Patients with Relapsed or Refractory Aggressive B- and T -Cell Non-Hodgkin's Lymphoma (NU Prot# NU 04H4)
Gordon, L. I. (PD/PI), Gordon, L. I. (Co-PD/PI), Kuzel, T. M. (Co-PD/PI), Mehta, J. (Co-PD/PI), Platanias, L. C. (Co-PD/PI), Singhal, S. (Co-PD/PI), Tallman, M. S. (Co-PD/PI), Williams, S. F. (Co-PD/PI) & Winter, J. N. (Co-PD/PI)
Millennium Pharmaceuticals, Inc.
7/8/05 → 10/31/14
Project: Research project
-
Prot# C-447: A Phase I Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Assessment of CG53135-05 Administered Intravenously in Patients with Oral Mucositis After Receiving Autologous Stem Cell Transplant (Multiple Rising-Dose Tolera
Mehta, J. (PD/PI)
Prologue Research International, Inc., CuraGen Corporation
4/15/05 → 9/30/09
Project: Research project
-
Prot# C-421: Phase II, Mltctr, Rndmzd, Dbl-Bld, Placebo-Cntrl'd Trial of Safety & Efficacy of CG53135-05 Administered Intravenously as a Single Dose for Prevention of Oral Mucositis in Patients Receiving Autologous Hematopoietic Stem Cell Transplant
Mehta, J. (PD/PI)
PPD Development, CuraGen Corporation
4/5/05 → 12/1/11
Project: Research project
-
Development of a Clinical Grade Cell Engineering Facility for the Hemotopoietic Stem Cell Transplantation Programs (SCT) of Northwestern Memorial Hospital
Mehta, J. (PD/PI)
Northwestern Memorial Foundation
9/1/04 → 8/31/09
Project: Research project
-
Prot# COM1.3: Evaluation of Immunol Oral Rinse for the Management of Oral Mucositis in Cancer Patients Undergoing Radiation and/or Chemotherapy Conditioning for Autologous Bone Marrow Transplantation
Mehta, J. (PD/PI)
Endo Pharmaceuticals Inc., BML Pharmaceuticals Inc.
8/27/02 → 3/7/05
Project: Research project